There are circumstances crueler than death, and Alzheimer’s disease may be one of them. For patients and their families, suffering from and witnessing the deterioration of mental and physical faculties is utterly devastating. From that angle, I completely understand the moral sentiment bolstering Cassava Sciences (NASDAQ:SAVA). We all want SAVA stock to win because it…

Millions of Americans are struggling with Alzheimer’s, according to the Alzheimer’s Association. The disease often has a slow progression, lasting years or even decades, and it’s one of the leading causes of death in the United States. Memory loss and declines in the ability to think clearly, solve problems, and even communicate are a terrible part…

InvestorPlace – Stock Market News, Stock Advice & Trading Tips Shares of ANVS stock are plummeting on Thursday after Annovis Bio reported weak results from two clinical trials for its leading drug. The post ANVS Stock: The Alzheimer’s Drug News That Has Annovis Bio Plunging Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy…